Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
about
Primary gastrointestinal stromal tumors: Current advances in diagnostic biomarkers, prognostic factors and management of its duodenal locationGastrointestinal stromal tumor.Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors.Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.Molecular basis and management of gastrointestinal stromal tumorsClinical and therapeutic considerations of GISTPreoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.A gist of gastrointestinal stromal tumors: A review.Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.Gastrointestinal tumors of the colon and rectumState of the Art in the Treatment of Gastrointestinal Stromal Tumors.Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II TrialACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.A Case of Malignant Gastrointestinal Stromal Tumor Initially Misdiagnosed as Malignant B-Cell LymphomaGastrointestinal stromal tumours at present: an approach to burning questions.The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor.How best to manage gastrointestinal stromal tumor.Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.Current and emerging pharmacological treatments for gastrointestinal stromal tumour.Surgical options for localized and advanced gastrointestinal stromal tumors.Adjuvant therapy of gastrointestinal stromal tumors (GIST).The role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors.Management of gastrointestinal stromal tumors.Surgical management of localized soft tissue tumors.Surgical management of GIST and intra-abdominal visceral leiomyosarcomas.Get the GIST? An overview of gastrointestinal stromal tumours.Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review.Practical Issues for Retroperitoneal Sarcoma.Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.Sunitinib as first-line neoadjuvant therapy in two patients with rectal stromal tumors.High CD133 expression levels in gastrointestinal stromal tumors.Gastrointestinal stromal tumor: a rare abdominal tumor.Retrospective study of laparoscopic versus open gastric resection for gastric gastrointestinal stromal tumors based on the propensity score matching method.Effective Downsizing of a Large Oesophageal Gastrointestinal Stromal Tumour with Neoadjuvant Imatinib Enabling an Uncomplicated and without Tumour Rupture Laparoscopic-Assisted Ivor-Lewis Oesophagectomy.Laparoscopic resection of a gastrointestinal stromal tumor of the lower rectum in a patient with coronary artery disease following long-term neoadjuvant imatinib treatment and anticoagulation therapy.Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report.Accomplishments in 2008 in the management of gastrointestinal stromal tumors.
P2860
Q26829970-24CFC68B-8DFD-488E-AFB4-9AF82EBC7E9DQ33489084-DB856206-6EE5-4B14-93DD-052D57B2C550Q33624278-C9000B85-C5DF-4F14-8A05-A0E5CA9A8AA7Q33644791-6D57A34C-BB41-4CAD-9E51-FD8CD612DC61Q33903598-01A8AC68-2701-4CDE-AF72-30E190BCB8DDQ34341168-29F371E9-44F3-48B0-AFFA-9F107B823D4AQ34628804-E1DB619C-1924-4E74-BD57-33B5556E2497Q34654203-0F60E8FD-2488-47A8-B711-41D7CE5E4823Q34660414-D7299D99-6EFE-4F81-9055-FBB9F040F8A6Q34664305-0AC62FE1-3FB4-44ED-A514-6985F200A155Q35111851-5D37BA6E-D822-47EE-BAFC-70DA4397FAE7Q35850185-419EA580-AD0D-4859-94B3-6EE23F6274E9Q36344557-CE2E034B-1385-410B-A7AA-00E4A87B40DAQ36499861-E694E356-3D63-4C1E-9E33-40782A558E6CQ36793267-DE84D963-FF85-430E-A0F0-26545F7DBADEQ37081903-A8B44E09-75B6-49DF-ABA5-850205EA1027Q37692669-419082C4-A8FD-4400-8AF2-E1BEACBE9AB1Q37694432-5389E631-A968-4804-8736-E26F9D84A949Q37743051-2241E61A-CA36-4CC2-B7DF-D3C4BADA9B2DQ37747750-6D742E2A-8833-4E15-A263-925E6B17C6FAQ37801294-74E5A6AD-59CC-409D-8E51-A0D8C9C1F09BQ37841551-EC4746CC-66CC-4F42-AD8A-143BBC25BA18Q37850393-A9DBC288-8A1F-4FBD-AB45-EE1A306B926EQ38022443-FB948B03-1B38-475D-B92F-D5B3DDAE03EEQ38048820-32A0DD5C-D055-4A65-96A2-C938F70D97FDQ38081983-16EA15D5-02AF-4304-BF0D-34A545D0ED79Q38206158-F1713E4F-8E6A-4A7B-B5AE-3138D5108C9FQ38261813-70292E1F-BB60-4C2F-AAF1-7F835609CAD6Q38718860-A951ACC8-7843-4EAC-931D-C2E08715163CQ38915858-2B289AB1-AEC9-42CD-8161-F65E1C5F8953Q38936009-B50F5519-2E92-4E4F-9A91-947222A66676Q39041739-FE0F5F5B-C16A-481D-AE66-83E1070ABC83Q39362495-2B910EFB-7EC0-40AE-AD97-07AFAE329A52Q39564970-0BA5A968-B0A1-42EF-82C2-9C4F13D9709DQ39636769-0E3DAB12-A79D-4808-9B90-1E46FDEFCB93Q39692076-A6F343E3-A48C-4375-AE91-0C2790783005Q40812894-27ABECE8-82E3-4F29-B221-6E0E9755E94FQ41770350-10BBF06D-6F89-495C-AA60-74470B6BF475Q41994931-1AFA706F-D194-4AFD-B0D2-216550389CBBQ42287336-C3AE4C51-FAB1-4E9B-A508-F1B6811492DD
P2860
Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Preoperative imatinib mesylate ...... estinal stromal tumors (GIST).
@ast
Preoperative imatinib mesylate ...... estinal stromal tumors (GIST).
@en
Preoperative imatinib mesylate ...... astrointestinal stromal tumors
@nl
type
label
Preoperative imatinib mesylate ...... estinal stromal tumors (GIST).
@ast
Preoperative imatinib mesylate ...... estinal stromal tumors (GIST).
@en
Preoperative imatinib mesylate ...... astrointestinal stromal tumors
@nl
prefLabel
Preoperative imatinib mesylate ...... estinal stromal tumors (GIST).
@ast
Preoperative imatinib mesylate ...... estinal stromal tumors (GIST).
@en
Preoperative imatinib mesylate ...... astrointestinal stromal tumors
@nl
P50
P1476
Preoperative imatinib mesylate ...... testinal stromal tumors (GIST)
@en
P2093
E Pennacchioli
P304
P356
10.1016/J.EJSO.2008.11.005
P50
P577
2008-12-24T00:00:00Z